Search

Your search keyword '"A. B. Kaye"' showing total 1,518 results

Search Constraints

Start Over You searched for: Author "A. B. Kaye" Remove constraint Author: "A. B. Kaye"
1,518 results on '"A. B. Kaye"'

Search Results

1. Microbial keratitis in Southern Malawi: a microbiological pilot study

4. Average paraxial power of a lens and visual acuity

5. Predicting Wildfire Ember Hot-Spots on Gable Roofs via Deep Learning

9. Preoperative surgeon evaluation of corneal endothelial status: the Viability Control of Human Endothelial Cells before Keratoplasty (V-CHECK) study protocol

10. Antimicrobial Effect of Nitric Oxide Releasing Hydrogels on Staphylococcus Aureus Derived Proteases

12. Specific decellularized extracellular matrix promotes the plasticity of human ocular surface epithelial cells

14. Potential new fluoroquinolone treatments for suspected bacterial keratitis

15. Cost analysis of eye bank versus surgeon prepared endothelial grafts

16. Endothelial failure and rejection in recipients of corneas from the same donor

17. Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer

19. Candida Parapsilosis associated rice bodies in the extensor compartment of the wrist––an emerging finding

20. Biomaterials for corneal endothelial cell culture and tissue engineering

22. Shotgun sequencing to determine corneal infection

24. Surgical goniolens for tag identification and removal in DMEK surgery

25. Factors Affecting the Success Rate of Preloaded Descemet Membrane Endothelial Keratoplasty With Endothelium-Inward Technique: A Multicenter Clinical Study

26. Descemet Membrane Endothelial Keratoplasty - Complication and management of a single case for tissue preparation and graft size linked to post-op descemetorhexis disparity

27. Possible Role of Descemet–Stroma Interface for Descemet's Membrane Detachment after Penetrating Keratoplasty

28. Increasing Donor Endothelial Cell Pool by Culturing Cells from Discarded Pieces of Human Donor Corneas for Regenerative Treatments

31. Low-Dose Propofol with Peribulbar Anaesthesia for Cataract Surgery

32. Supplementary Table 1 from Ovarian Cancer Stem Cell–Like Side Populations Are Enriched Following Chemotherapy and Overexpress EZH2

33. Supplementary Table 1 from Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation

35. Supplementary Table 2 from Ovarian Cancer Stem Cell–Like Side Populations Are Enriched Following Chemotherapy and Overexpress EZH2

36. Supplementary Data from The Association of PI3 Kinase Signaling and Chemoresistance in Advanced Ovarian Cancer

37. Supplementary Table 2 from Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation

38. Supplementary Table 3 from Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation

41. Data from Ovarian Cancer Stem Cell–Like Side Populations Are Enriched Following Chemotherapy and Overexpress EZH2

42. Supplementary Table 4 from Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation

44. Supplementary Figure 1 from Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation

46. Supplementary Tables 1 - 4 from Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome

47. Data from Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome

48. Supplementary Table 5 from Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation

50. Supplementary Table 1 from Modulation of Plasma Metabolite Biomarkers of the MAPK Pathway with MEK Inhibitor RO4987655: Pharmacodynamic and Predictive Potential in Metastatic Melanoma

Catalog

Books, media, physical & digital resources